4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-21-055311
EVP, Research & CSO sold 4,125 shares at an average $49.67 ($204,875)
- EVP, Research & CSO acquired 4,125 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Virgin Herbert · EVP, Research & CSO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-09-07 | Exercise or conversion : show line 1 in the form | +4,125 | $1.53 | $6,311 | 103,825 | D |
| 2021-09-07 | Sale : show line 2 in the form | −1,375 | $49.00 | $67,375 | 102,450 | D |
| 2021-09-07 | Sale : show line 3 in the form | −2,750 | $50.00 | $137,500 | 99,700 | D |
| Open-market sales · 4,125 sh · avg $49.67 · $204,875 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-09-07 | Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) | −4,125 | 263,255 | D |
Loading xslF345X03/doc4.xml…